Afya Limited (AFYA) 10-Year Financial Performance & Capital Metrics

AFYA • • Industrial / General

Consumer DefensiveEducation & TrainingHigher Education & Professional TrainingMedical & Healthcare Education

AboutAfya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.Show more

Revenue $3.3B +14.9%
EBITDA $1.22B +15.1%
Net Income $632M +63.5%
EPS (Diluted) 6.93 +62.3%
Gross Margin 63.21% +2.9%
EBITDA Margin 36.81% +0.2%
Operating Margin 30.63% +14.8%
Net Margin 19.11% +42.3%
ROE 15.88% +41.7%
ROIC 12.3% +13.8%
Debt/Equity 0.74 +0.2%
Interest Coverage 2.76 +39.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 32.6%
✓FCF machine: 31.5% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 34.5%
✓Healthy 5Y average net margin of 17.2%
✓Trading at only 0.3x book value

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y34.5%

3Y24.33%

TTM14.07%

Profit (Net Income) CAGR

10Y-

5Y32.62%

3Y41.41%

TTM25.84%

EPS CAGR

10Y-

5Y27.96%

3Y43%

TTM25.63%

ROCE

10Y Avg23.66%

5Y Avg11.39%

3Y Avg12.43%

Latest14.24%

Peer Comparison

Medical & Healthcare Education

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ATGEAdtalem Global Education Inc.	4.26B	117.39	19.34	12.85%	13.74%	17.29%	6.74%	0.54
AFYAAfya Limited	674.82M	14.39	2.08	14.9%	20.08%	15.24%	100%	0.74

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	216.01M	333.94M	750.63M	1.2B	1.72B	2.33B	2.88B	3.3B
Revenue Growth %	-	0.55%	1.25%	0.6%	0.43%	0.35%	0.23%	0.15%
Cost of Goods Sold+	124.06M	168.05M	308.85M	434.65M	652.3M	859.55M	1.11B	1.22B
COGS % of Revenue	0.57%	0.5%	0.41%	0.36%	0.38%	0.37%	0.39%	0.37%
Gross Profit+	91.94M	165.88M	441.78M	766.54M	1.07B	1.47B	1.77B	2.09B
Gross Margin %	0.43%	0.5%	0.59%	0.64%	0.62%	0.63%	0.61%	0.63%
Gross Profit Growth %	-	0.8%	1.66%	0.74%	0.39%	0.38%	0.2%	0.18%
Operating Expenses+	42.6M	69.44M	236.53M	403.2M	626.18M	805.58M	999.04M	1.08B
OpEx % of Revenue	0.2%	0.21%	0.32%	0.34%	0.36%	0.35%	0.35%	0.33%
Selling, General & Admin	45.35M	70.03M	239.12M	402.86M	622.62M	798.15M	1.01B	1.07B
SG&A % of Revenue	0.21%	0.21%	0.32%	0.34%	0.36%	0.34%	0.35%	0.32%
Research & Development	0	0	0	32K	0	9.44M	21.5M	20.09M
R&D % of Revenue	-	-	-	0%	-	0%	0.01%	0.01%
Other Operating Expenses	-2.75M	-599K	-2.59M	347K	3.56M	0	-37.15M	-11M
Operating Income+	49.34M	96.45M	205.25M	363.33M	440.89M	664.1M	767.06M	1.01B
Operating Margin %	0.23%	0.29%	0.27%	0.3%	0.26%	0.29%	0.27%	0.31%
Operating Income Growth %	-	0.95%	1.13%	0.77%	0.21%	0.51%	0.16%	0.32%
EBITDA+	53.52M	106.07M	278.4M	472.84M	595.12M	876.04M	1.06B	1.22B
EBITDA Margin %	0.25%	0.32%	0.37%	0.39%	0.35%	0.38%	0.37%	0.37%
EBITDA Growth %	-	0.98%	1.62%	0.7%	0.26%	0.47%	0.21%	0.15%
D&A (Non-Cash Add-back)	4.18M	9.62M	73.15M	109.5M	154.22M	211.94M	289.51M	204.12M
EBIT	49.34M	96.45M	242.41M	363.33M	449.11M	717.09M	815.88M	1.01B
Net Interest Income+	-381K	-573K	-51.38M	-9.22M	-152.61M	-261.45M	-279.17M	-322.94M
Interest Income	3.17M	4.36M	9.04M	7.05M	23.04M	27.2M	107.12M	43.42M
Interest Expense	1.04M	2.4M	15.94M	16.27M	175.65M	288.65M	386.3M	366.35M
Other Income/Expense	1.64M	2.27M	-18.31M	-28.28M	-167.43M	-235.67M	-337.48M	-335.72M
Pretax Income+	50.98M	98.72M	186.94M	335.05M	273.46M	428.43M	429.58M	676.39M
Pretax Margin %	0.24%	0.3%	0.25%	0.28%	0.16%	0.18%	0.15%	0.2%
Income Tax+	2.5M	3.99M	14.18M	27.07M	31.18M	35.68M	24.17M	27.47M
Effective Tax Rate %	0.89%	0.87%	0.82%	0.87%	0.82%	0.87%	0.9%	0.93%
Net Income+	45.39M	86.35M	153.92M	292.07M	223.33M	373.57M	386.32M	631.51M
Net Margin %	0.21%	0.26%	0.21%	0.24%	0.13%	0.16%	0.13%	0.19%
Net Income Growth %	-	0.9%	0.78%	0.9%	-0.24%	0.67%	0.03%	0.63%
Net Income (Continuing)	48.48M	94.73M	172.76M	307.99M	242.28M	392.76M	405.42M	648.92M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	651K	88.37M	48.63M	51.56M	51.87M	51.32M	41.51M	40.63M
EPS (Diluted)+	0.52	0.98	2.02	3.12	2.37	4.15	4.27	6.93
EPS Growth %	-	0.88%	1.06%	0.54%	-0.24%	0.75%	0.03%	0.62%
EPS (Basic)	0.52	0.98	2.03	3.15	2.39	4.15	4.27	7.01
Diluted Shares Outstanding	87.68M	87.68M	76.19M	93.64M	94.1M	89.94M	90.54M	91.15M
Basic Shares Outstanding	87.68M	87.68M	75.97M	92.68M	93.29M	89.94M	90.47M	90.12M
Dividend Payout Ratio	-	-	0.25%	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	60.48M	133.5M	1.11B	1.41B	1.21B	1.64B	1.2B	1.59B
Cash & Short-Term Investments	25.49M	62.26M	943.21M	1.05B	748.56M	1.09B	553.03M	911.01M
Cash Only	25.49M	62.26M	943.21M	1.05B	748.56M	1.09B	553.03M	911.01M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	31.13M	58.45M	125.44M	302.32M	403.93M	480.64M	546.44M	621.62M
Days Sales Outstanding	52.6	63.88	61	91.86	85.75	75.32	69.35	68.67
Inventory	448K	1.11M	3.93M	7.51M	11.83M	12.19M	1.38M	0
Days Inventory Outstanding	1.32	2.42	4.65	6.31	6.62	5.18	0.45	-
Other Current Assets	3.41M	11.12M	164.62M	50.63M	42.53M	51.74M	102.66M	57.15M
Total Non-Current Assets+	43.15M	784.92M	1.8B	3.39B	5.24B	5.56B	6.38B	7.24B
Property, Plant & Equipment	32.48M	65.76M	413.6M	679.46M	1.08B	1.23B	1.38B	1.5B
Fixed Asset Turnover	6.65x	5.08x	1.81x	1.77x	1.59x	1.89x	2.09x	2.20x
Goodwill	0	169.53M	459.41M	810.66M	1.18B	1.26B	1.33B	1.53B
Intangible Assets	4.73M	512.93M	852.93M	1.76B	2.72B	2.78B	3.46B	4.01B
Long-Term Investments	3.26M	26.31M	45.63M	51.41M	48.48M	53.91M	51.83M	54.44M
Other Non-Current Assets	5.94M	36.69M	19.32M	76.09M	207.75M	234.32M	156.83M	151.82M
Total Assets+	103.63M	918.42M	2.91B	4.79B	6.45B	7.2B	7.58B	8.83B
Asset Turnover	2.08x	0.36x	0.26x	0.25x	0.27x	0.32x	0.38x	0.37x
Asset Growth %	-	7.86%	2.17%	0.65%	0.35%	0.12%	0.05%	0.16%
Total Current Liabilities+	51.94M	182.33M	333.23M	589.38M	766.51M	905.69M	1.06B	1.14B
Accounts Payable	6.74M	8.1M	149.51M	224.16M	298.95M	333.19M	108.22M	128.08M
Days Payables Outstanding	19.83	17.6	176.69	188.24	167.28	141.49	35.59	38.46
Short-Term Debt	1.16M	26.8M	53.61M	117.67M	143.2M	207.38M	179.25M	363.55M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	0	0
Other Current Liabilities	24.14M	108.99M	47.9M	84.19M	146.46M	157.24M	514.14M	361.45M
Current Ratio	1.16x	0.73x	3.34x	2.38x	1.57x	1.81x	1.14x	1.39x
Quick Ratio	1.16x	0.73x	3.32x	2.37x	1.56x	1.79x	1.14x	1.39x
Cash Conversion Cycle	34.09	48.7	-111.05	-90.07	-74.91	-60.99	34.21	-
Total Non-Current Liabilities+	4.92M	145.73M	465.5M	1.37B	2.68B	3.04B	2.88B	3.38B
Long-Term Debt	2.66M	51.03M	6.75M	576M	1.3B	1.74B	1.62B	1.83B
Capital Lease Obligations	0	0	261.82M	385.73M	689.13M	737.07M	837.67M	932.76M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	2.26M	94.7M	196.93M	408.21M	687.35M	568.93M	423.71M	614.4M
Total Liabilities	56.86M	328.06M	798.73M	1.96B	3.45B	3.95B	3.94B	4.52B
Total Debt+	3.82M	77.83M	344.87M	1.14B	2.16B	2.71B	2.68B	3.17B
Net Debt	-21.67M	15.57M	-598.34M	96.33M	1.41B	1.62B	2.12B	2.26B
Debt / Equity	0.08x	0.13x	0.16x	0.40x	0.72x	0.84x	0.73x	0.74x
Debt / EBITDA	0.07x	0.73x	1.24x	2.41x	3.63x	3.10x	2.53x	2.61x
Net Debt / EBITDA	-0.40x	0.15x	-2.15x	0.20x	2.37x	1.85x	2.01x	1.86x
Interest Coverage	47.35x	40.12x	12.88x	22.33x	2.51x	2.30x	1.99x	2.76x
Total Equity+	46.76M	590.35M	2.11B	2.83B	3B	3.25B	3.64B	4.31B
Equity Growth %	-	11.62%	2.58%	0.34%	0.06%	0.08%	0.12%	0.18%
Book Value per Share	0.53	6.73	27.74	30.26	31.88	36.14	40.24	47.29
Total Shareholders' Equity	46.11M	501.98M	2.07B	2.78B	2.95B	3.2B	3.6B	4.27B
Common Stock	66.48M	315M	17K	17K	17K	17K	17K	17K
Retained Earnings	40.31M	52.58M	115.92M	407.99M	631.32M	1B	1.38B	2.01B
Treasury Stock	0	0	0	0	-152.63M	-304.95M	-299.15M	-273.95M
Accumulated OCI	43.21M	59.81M	115.92M	50.72M	0	0	0	187.5M
Minority Interest	651K	88.37M	48.63M	51.56M	51.87M	51.32M	41.51M	40.63M

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	39.92M	80.32M	299.22M	371.51M	630.87M	843.9M	1.04B	1.43B
Operating CF Margin %	0.18%	0.24%	0.4%	0.31%	0.37%	0.36%	0.36%	0.43%
Operating CF Growth %	-	1.01%	2.73%	0.24%	0.7%	0.34%	0.24%	0.37%
Net Income	50.98M	98.72M	186.94M	335.05M	273.46M	428.43M	429.58M	676.39M
Depreciation & Amortization	4.02M	9.08M	73.15M	108.74M	154.22M	206.22M	289.51M	333.34M
Stock-Based Compensation	0	2.16M	18.11M	32.61M	43.38M	31.27M	31.54M	32.42M
Deferred Taxes	0	5.29M	-9.86M	0	0	0	0	0
Other Non-Cash Items	-427K	1.5M	55.47M	64.24M	208.6M	287.89M	352.39M	409.87M
Working Capital Changes	-14.66M	-36.44M	-24.6M	-169.14M	-48.8M	-109.92M	-59.39M	-19.36M
Change in Receivables	-9.79M	-28.2M	-35.56M	-178M	-81.99M	-129.16M	-131.34M	-79.34M
Change in Inventory	-140K	-593K	-236K	-3.11M	-3.72M	-363K	10.95M	0
Change in Payables	-2.38M	-1.53M	3.03M	4.47M	14.48M	9.97M	24.5M	18.13M
Cash from Investing+	-22.07M	-262.39M	-354.15M	-1.04B	-1.27B	-591.47M	-1.14B	-1.09B
Capital Expenditures	-21.07M	-21.69M	-121.71M	-89.83M	-125.87M	-297.02M	-118.44M	-136.92M
CapEx % of Revenue	0.1%	0.06%	0.16%	0.07%	0.07%	0.13%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-1M	-19.4M	9.13M	-32.97M	-143.17M	6.75M	-117.09M	-327.12M
Cash from Financing+	-4.13M	218.84M	921.43M	756.42M	364.68M	92.94M	-439.94M	23.97M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	-38.75M	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-2.51M	150.46M	36.15M	-27.24M	-103.3M	-221.32M	-288.76M	-297.71M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	18.85M	58.63M	177.51M	233.92M	354.07M	546.88M	798.2M	1.04B
FCF Margin %	0.09%	0.18%	0.24%	0.19%	0.21%	0.23%	0.28%	0.31%
FCF Growth %	-	2.11%	2.03%	0.32%	0.51%	0.54%	0.46%	0.3%
FCF per Share	0.21	0.67	2.33	2.50	3.76	6.08	8.82	11.41
FCF Conversion (FCF/Net Income)	0.88x	0.93x	1.94x	1.27x	2.82x	2.26x	2.70x	2.27x
Interest Paid	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	97.07%	27.11%	11.38%	11.81%	7.66%	11.95%	11.21%	15.88%
Return on Invested Capital (ROIC)	147.47%	22.93%	14.51%	12.26%	9.01%	10.73%	10.82%	12.3%
Gross Margin	42.56%	49.68%	58.85%	63.81%	62.06%	63.09%	61.41%	63.21%
Net Margin	21.01%	25.86%	20.5%	24.32%	12.99%	16.04%	13.43%	19.11%
Debt / Equity	0.08x	0.13x	0.16x	0.40x	0.72x	0.84x	0.73x	0.74x
Interest Coverage	47.35x	40.12x	12.88x	22.33x	2.51x	2.30x	1.99x	2.76x
FCF Conversion	0.88x	0.93x	1.94x	1.27x	2.82x	2.26x	2.70x	2.27x
Revenue Growth	-	54.59%	124.78%	60.02%	43.14%	35.46%	23.48%	14.9%

Frequently Asked Questions

Valuation & Price

Afya Limited (AFYA) has a price-to-earnings (P/E) ratio of 2.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Afya Limited (AFYA) reported $3.63B in revenue for fiscal year 2024. This represents a 1582% increase from $216.0M in 2017.

Afya Limited (AFYA) grew revenue by 14.9% over the past year. This is steady growth.

Yes, Afya Limited (AFYA) is profitable, generating $729.4M in net income for fiscal year 2024 (19.1% net margin).

Dividend & Returns

Afya Limited (AFYA) has a return on equity (ROE) of 15.9%. This is reasonable for most industries.

Afya Limited (AFYA) generated $1.26B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Afya Limited (AFYA) 10-Year Financial Performance & Capital Metrics

AFYA • • Industrial / General

Consumer DefensiveEducation & TrainingHigher Education & Professional TrainingMedical & Healthcare Education

Revenue $3.3B +14.9%
EBITDA $1.22B +15.1%
Net Income $632M +63.5%
EPS (Diluted) 6.93 +62.3%
Gross Margin 63.21% +2.9%
EBITDA Margin 36.81% +0.2%
Operating Margin 30.63% +14.8%
Net Margin 19.11% +42.3%
ROE 15.88% +41.7%
ROIC 12.3% +13.8%
Debt/Equity 0.74 +0.2%
Interest Coverage 2.76 +39.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 32.6%
✓FCF machine: 31.5% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 34.5%
✓Healthy 5Y average net margin of 17.2%
✓Trading at only 0.3x book value

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y34.5%

3Y24.33%

TTM14.07%

Profit (Net Income) CAGR

10Y-

5Y32.62%

3Y41.41%

TTM25.84%

EPS CAGR

10Y-

5Y27.96%

3Y43%

TTM25.63%

ROCE

10Y Avg23.66%

5Y Avg11.39%

3Y Avg12.43%

Latest14.24%

Peer Comparison

Medical & Healthcare Education

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ATGEAdtalem Global Education Inc.	4.26B	117.39	19.34	12.85%	13.74%	17.29%	6.74%	0.54
AFYAAfya Limited	674.82M	14.39	2.08	14.9%	20.08%	15.24%	100%	0.74

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	216.01M	333.94M	750.63M	1.2B	1.72B	2.33B	2.88B	3.3B
Revenue Growth %	-	0.55%	1.25%	0.6%	0.43%	0.35%	0.23%	0.15%
Cost of Goods Sold+	124.06M	168.05M	308.85M	434.65M	652.3M	859.55M	1.11B	1.22B
COGS % of Revenue	0.57%	0.5%	0.41%	0.36%	0.38%	0.37%	0.39%	0.37%
Gross Profit+	91.94M	165.88M	441.78M	766.54M	1.07B	1.47B	1.77B	2.09B
Gross Margin %	0.43%	0.5%	0.59%	0.64%	0.62%	0.63%	0.61%	0.63%
Gross Profit Growth %	-	0.8%	1.66%	0.74%	0.39%	0.38%	0.2%	0.18%
Operating Expenses+	42.6M	69.44M	236.53M	403.2M	626.18M	805.58M	999.04M	1.08B
OpEx % of Revenue	0.2%	0.21%	0.32%	0.34%	0.36%	0.35%	0.35%	0.33%
Selling, General & Admin	45.35M	70.03M	239.12M	402.86M	622.62M	798.15M	1.01B	1.07B
SG&A % of Revenue	0.21%	0.21%	0.32%	0.34%	0.36%	0.34%	0.35%	0.32%
Research & Development	0	0	0	32K	0	9.44M	21.5M	20.09M
R&D % of Revenue	-	-	-	0%	-	0%	0.01%	0.01%
Other Operating Expenses	-2.75M	-599K	-2.59M	347K	3.56M	0	-37.15M	-11M
Operating Income+	49.34M	96.45M	205.25M	363.33M	440.89M	664.1M	767.06M	1.01B
Operating Margin %	0.23%	0.29%	0.27%	0.3%	0.26%	0.29%	0.27%	0.31%
Operating Income Growth %	-	0.95%	1.13%	0.77%	0.21%	0.51%	0.16%	0.32%
EBITDA+	53.52M	106.07M	278.4M	472.84M	595.12M	876.04M	1.06B	1.22B
EBITDA Margin %	0.25%	0.32%	0.37%	0.39%	0.35%	0.38%	0.37%	0.37%
EBITDA Growth %	-	0.98%	1.62%	0.7%	0.26%	0.47%	0.21%	0.15%
D&A (Non-Cash Add-back)	4.18M	9.62M	73.15M	109.5M	154.22M	211.94M	289.51M	204.12M
EBIT	49.34M	96.45M	242.41M	363.33M	449.11M	717.09M	815.88M	1.01B
Net Interest Income+	-381K	-573K	-51.38M	-9.22M	-152.61M	-261.45M	-279.17M	-322.94M
Interest Income	3.17M	4.36M	9.04M	7.05M	23.04M	27.2M	107.12M	43.42M
Interest Expense	1.04M	2.4M	15.94M	16.27M	175.65M	288.65M	386.3M	366.35M
Other Income/Expense	1.64M	2.27M	-18.31M	-28.28M	-167.43M	-235.67M	-337.48M	-335.72M
Pretax Income+	50.98M	98.72M	186.94M	335.05M	273.46M	428.43M	429.58M	676.39M
Pretax Margin %	0.24%	0.3%	0.25%	0.28%	0.16%	0.18%	0.15%	0.2%
Income Tax+	2.5M	3.99M	14.18M	27.07M	31.18M	35.68M	24.17M	27.47M
Effective Tax Rate %	0.89%	0.87%	0.82%	0.87%	0.82%	0.87%	0.9%	0.93%
Net Income+	45.39M	86.35M	153.92M	292.07M	223.33M	373.57M	386.32M	631.51M
Net Margin %	0.21%	0.26%	0.21%	0.24%	0.13%	0.16%	0.13%	0.19%
Net Income Growth %	-	0.9%	0.78%	0.9%	-0.24%	0.67%	0.03%	0.63%
Net Income (Continuing)	48.48M	94.73M	172.76M	307.99M	242.28M	392.76M	405.42M	648.92M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	651K	88.37M	48.63M	51.56M	51.87M	51.32M	41.51M	40.63M
EPS (Diluted)+	0.52	0.98	2.02	3.12	2.37	4.15	4.27	6.93
EPS Growth %	-	0.88%	1.06%	0.54%	-0.24%	0.75%	0.03%	0.62%
EPS (Basic)	0.52	0.98	2.03	3.15	2.39	4.15	4.27	7.01
Diluted Shares Outstanding	87.68M	87.68M	76.19M	93.64M	94.1M	89.94M	90.54M	91.15M
Basic Shares Outstanding	87.68M	87.68M	75.97M	92.68M	93.29M	89.94M	90.47M	90.12M
Dividend Payout Ratio	-	-	0.25%	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	60.48M	133.5M	1.11B	1.41B	1.21B	1.64B	1.2B	1.59B
Cash & Short-Term Investments	25.49M	62.26M	943.21M	1.05B	748.56M	1.09B	553.03M	911.01M
Cash Only	25.49M	62.26M	943.21M	1.05B	748.56M	1.09B	553.03M	911.01M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	31.13M	58.45M	125.44M	302.32M	403.93M	480.64M	546.44M	621.62M
Days Sales Outstanding	52.6	63.88	61	91.86	85.75	75.32	69.35	68.67
Inventory	448K	1.11M	3.93M	7.51M	11.83M	12.19M	1.38M	0
Days Inventory Outstanding	1.32	2.42	4.65	6.31	6.62	5.18	0.45	-
Other Current Assets	3.41M	11.12M	164.62M	50.63M	42.53M	51.74M	102.66M	57.15M
Total Non-Current Assets+	43.15M	784.92M	1.8B	3.39B	5.24B	5.56B	6.38B	7.24B
Property, Plant & Equipment	32.48M	65.76M	413.6M	679.46M	1.08B	1.23B	1.38B	1.5B
Fixed Asset Turnover	6.65x	5.08x	1.81x	1.77x	1.59x	1.89x	2.09x	2.20x
Goodwill	0	169.53M	459.41M	810.66M	1.18B	1.26B	1.33B	1.53B
Intangible Assets	4.73M	512.93M	852.93M	1.76B	2.72B	2.78B	3.46B	4.01B
Long-Term Investments	3.26M	26.31M	45.63M	51.41M	48.48M	53.91M	51.83M	54.44M
Other Non-Current Assets	5.94M	36.69M	19.32M	76.09M	207.75M	234.32M	156.83M	151.82M
Total Assets+	103.63M	918.42M	2.91B	4.79B	6.45B	7.2B	7.58B	8.83B
Asset Turnover	2.08x	0.36x	0.26x	0.25x	0.27x	0.32x	0.38x	0.37x
Asset Growth %	-	7.86%	2.17%	0.65%	0.35%	0.12%	0.05%	0.16%
Total Current Liabilities+	51.94M	182.33M	333.23M	589.38M	766.51M	905.69M	1.06B	1.14B
Accounts Payable	6.74M	8.1M	149.51M	224.16M	298.95M	333.19M	108.22M	128.08M
Days Payables Outstanding	19.83	17.6	176.69	188.24	167.28	141.49	35.59	38.46
Short-Term Debt	1.16M	26.8M	53.61M	117.67M	143.2M	207.38M	179.25M	363.55M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	0	0
Other Current Liabilities	24.14M	108.99M	47.9M	84.19M	146.46M	157.24M	514.14M	361.45M
Current Ratio	1.16x	0.73x	3.34x	2.38x	1.57x	1.81x	1.14x	1.39x
Quick Ratio	1.16x	0.73x	3.32x	2.37x	1.56x	1.79x	1.14x	1.39x
Cash Conversion Cycle	34.09	48.7	-111.05	-90.07	-74.91	-60.99	34.21	-
Total Non-Current Liabilities+	4.92M	145.73M	465.5M	1.37B	2.68B	3.04B	2.88B	3.38B
Long-Term Debt	2.66M	51.03M	6.75M	576M	1.3B	1.74B	1.62B	1.83B
Capital Lease Obligations	0	0	261.82M	385.73M	689.13M	737.07M	837.67M	932.76M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	2.26M	94.7M	196.93M	408.21M	687.35M	568.93M	423.71M	614.4M
Total Liabilities	56.86M	328.06M	798.73M	1.96B	3.45B	3.95B	3.94B	4.52B
Total Debt+	3.82M	77.83M	344.87M	1.14B	2.16B	2.71B	2.68B	3.17B
Net Debt	-21.67M	15.57M	-598.34M	96.33M	1.41B	1.62B	2.12B	2.26B
Debt / Equity	0.08x	0.13x	0.16x	0.40x	0.72x	0.84x	0.73x	0.74x
Debt / EBITDA	0.07x	0.73x	1.24x	2.41x	3.63x	3.10x	2.53x	2.61x
Net Debt / EBITDA	-0.40x	0.15x	-2.15x	0.20x	2.37x	1.85x	2.01x	1.86x
Interest Coverage	47.35x	40.12x	12.88x	22.33x	2.51x	2.30x	1.99x	2.76x
Total Equity+	46.76M	590.35M	2.11B	2.83B	3B	3.25B	3.64B	4.31B
Equity Growth %	-	11.62%	2.58%	0.34%	0.06%	0.08%	0.12%	0.18%
Book Value per Share	0.53	6.73	27.74	30.26	31.88	36.14	40.24	47.29
Total Shareholders' Equity	46.11M	501.98M	2.07B	2.78B	2.95B	3.2B	3.6B	4.27B
Common Stock	66.48M	315M	17K	17K	17K	17K	17K	17K
Retained Earnings	40.31M	52.58M	115.92M	407.99M	631.32M	1B	1.38B	2.01B
Treasury Stock	0	0	0	0	-152.63M	-304.95M	-299.15M	-273.95M
Accumulated OCI	43.21M	59.81M	115.92M	50.72M	0	0	0	187.5M
Minority Interest	651K	88.37M	48.63M	51.56M	51.87M	51.32M	41.51M	40.63M

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	39.92M	80.32M	299.22M	371.51M	630.87M	843.9M	1.04B	1.43B
Operating CF Margin %	0.18%	0.24%	0.4%	0.31%	0.37%	0.36%	0.36%	0.43%
Operating CF Growth %	-	1.01%	2.73%	0.24%	0.7%	0.34%	0.24%	0.37%
Net Income	50.98M	98.72M	186.94M	335.05M	273.46M	428.43M	429.58M	676.39M
Depreciation & Amortization	4.02M	9.08M	73.15M	108.74M	154.22M	206.22M	289.51M	333.34M
Stock-Based Compensation	0	2.16M	18.11M	32.61M	43.38M	31.27M	31.54M	32.42M
Deferred Taxes	0	5.29M	-9.86M	0	0	0	0	0
Other Non-Cash Items	-427K	1.5M	55.47M	64.24M	208.6M	287.89M	352.39M	409.87M
Working Capital Changes	-14.66M	-36.44M	-24.6M	-169.14M	-48.8M	-109.92M	-59.39M	-19.36M
Change in Receivables	-9.79M	-28.2M	-35.56M	-178M	-81.99M	-129.16M	-131.34M	-79.34M
Change in Inventory	-140K	-593K	-236K	-3.11M	-3.72M	-363K	10.95M	0
Change in Payables	-2.38M	-1.53M	3.03M	4.47M	14.48M	9.97M	24.5M	18.13M
Cash from Investing+	-22.07M	-262.39M	-354.15M	-1.04B	-1.27B	-591.47M	-1.14B	-1.09B
Capital Expenditures	-21.07M	-21.69M	-121.71M	-89.83M	-125.87M	-297.02M	-118.44M	-136.92M
CapEx % of Revenue	0.1%	0.06%	0.16%	0.07%	0.07%	0.13%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-1M	-19.4M	9.13M	-32.97M	-143.17M	6.75M	-117.09M	-327.12M
Cash from Financing+	-4.13M	218.84M	921.43M	756.42M	364.68M	92.94M	-439.94M	23.97M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	-38.75M	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-2.51M	150.46M	36.15M	-27.24M	-103.3M	-221.32M	-288.76M	-297.71M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	18.85M	58.63M	177.51M	233.92M	354.07M	546.88M	798.2M	1.04B
FCF Margin %	0.09%	0.18%	0.24%	0.19%	0.21%	0.23%	0.28%	0.31%
FCF Growth %	-	2.11%	2.03%	0.32%	0.51%	0.54%	0.46%	0.3%
FCF per Share	0.21	0.67	2.33	2.50	3.76	6.08	8.82	11.41
FCF Conversion (FCF/Net Income)	0.88x	0.93x	1.94x	1.27x	2.82x	2.26x	2.70x	2.27x
Interest Paid	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	97.07%	27.11%	11.38%	11.81%	7.66%	11.95%	11.21%	15.88%
Return on Invested Capital (ROIC)	147.47%	22.93%	14.51%	12.26%	9.01%	10.73%	10.82%	12.3%
Gross Margin	42.56%	49.68%	58.85%	63.81%	62.06%	63.09%	61.41%	63.21%
Net Margin	21.01%	25.86%	20.5%	24.32%	12.99%	16.04%	13.43%	19.11%
Debt / Equity	0.08x	0.13x	0.16x	0.40x	0.72x	0.84x	0.73x	0.74x
Interest Coverage	47.35x	40.12x	12.88x	22.33x	2.51x	2.30x	1.99x	2.76x
FCF Conversion	0.88x	0.93x	1.94x	1.27x	2.82x	2.26x	2.70x	2.27x
Revenue Growth	-	54.59%	124.78%	60.02%	43.14%	35.46%	23.48%	14.9%

Frequently Asked Questions

Valuation & Price

Afya Limited (AFYA) has a price-to-earnings (P/E) ratio of 2.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Afya Limited (AFYA) reported $3.63B in revenue for fiscal year 2024. This represents a 1582% increase from $216.0M in 2017.

Afya Limited (AFYA) grew revenue by 14.9% over the past year. This is steady growth.

Yes, Afya Limited (AFYA) is profitable, generating $729.4M in net income for fiscal year 2024 (19.1% net margin).

Dividend & Returns

Afya Limited (AFYA) has a return on equity (ROE) of 15.9%. This is reasonable for most industries.

Afya Limited (AFYA) generated $1.26B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.